| EP3663387 - DEVICE AND METHOD FOR TREATING FLUIDS, PARTICULARLY BODY FLUIDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.07.2024 Database last updated on 19.03.2026 | |
| Former | The patent has been granted Status updated on 28.07.2023 | ||
| Former | Grant of patent is intended Status updated on 14.03.2023 | ||
| Former | Examination is in progress Status updated on 28.01.2021 | ||
| Former | Request for examination was made Status updated on 08.05.2020 | Most recent event Tooltip | 13.03.2026 | Lapse of the patent in a contracting state New state(s): HU | published on 15.04.2026 [2026/16] | Applicant(s) | For all designated states Bruker Daltonics GmbH & Co. KG Fahrenheitstraße 4 28359 Bremen / DE | [2021/47] |
| Former [2020/24] | For all designated states Bruker Daltonik GmbH Fahrenheitstrasse 4 28359 Bremen / DE | Inventor(s) | 01 /
Becker, Karsten Wibbeltweg 9 48366 Laer / DE | 02 /
Idelevich, Evgeny Einsteinstraße 22 48149 Münster / DE | [2020/24] | Representative(s) | Boßmeyer, Jens Bruker Daltonics GmbH & Co. KG Fahrenheitstraße 4 28359 Bremen / DE | [2023/35] |
| Former [2020/24] | Boßmeyer, Jens Bruker Daltonik GmbH Fahrenheitstraße 4 28359 Bremen / DE | Application number, filing date | 20152089.7 | 28.07.2016 | [2020/24] | Priority number, date | DE201510112343 | 29.07.2015 Original published format: DE102015112343 | [2020/24] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | EP3663387 | Date: | 10.06.2020 | Language: | DE | [2020/24] | Type: | B1 Patent specification | No.: | EP3663387 | Date: | 30.08.2023 | Language: | DE | [2023/35] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.03.2020 | Classification | IPC: | A61B5/15, C12Q1/04, C12M1/12, C12Q1/24, B01L3/00, G01N1/40, G01N33/49, A61B5/153, C12M1/00 | [2023/13] | CPC: |
C12Q1/04 (EP,US);
C12M23/00 (CN);
A61B5/15003 (EP);
A61B5/150236 (EP);
A61B5/150251 (EP);
A61B5/150755 (EP);
A61B5/153 (EP);
B01D29/01 (CN);
B01D29/58 (CN);
B01L3/502 (EP,US);
C12M23/04 (CN);
C12M23/10 (CN);
C12M23/38 (CN);
C12M23/44 (CN);
C12M23/52 (CN);
C12M27/10 (CN);
C12M33/04 (CN,US);
C12M33/14 (CN,US);
C12M37/02 (CN);
C12M41/12 (CN);
C12M43/00 (CN);
C12M47/04 (US);
C12Q1/24 (EP,US);
G01N1/4077 (EP,US);
B01L2200/141 (US);
B01L2300/0681 (EP,US);
B01L2400/0478 (EP,US);
B01L2400/0605 (EP,US);
C12M25/02 (US);
C12M47/02 (EP,US);
|
| Former IPC [2020/24] | C12M1/12, C12Q1/04, C12Q1/24, G01N33/49, B01L3/00, G01N1/40 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/24] | Title | German: | VORRICHTUNG UND VERFAHREN ZUM AUFBEREITEN VON FLÜSSIGKEITEN, INSBESONDERE KÖRPERFLÜSSIGKEITEN | [2020/24] | English: | DEVICE AND METHOD FOR TREATING FLUIDS, PARTICULARLY BODY FLUIDS | [2020/24] | French: | DISPOSITIF ET PROCÉDÉ DE TRAITEMENT DE LIQUIDES, NOTAMMENT DE LIQUIDES CORPORELS | [2020/24] | Examination procedure | 31.01.2020 | Examination requested [2020/24] | 27.01.2021 | Despatch of a communication from the examining division (Time limit: M02) | 10.03.2021 | Reply to a communication from the examining division | 08.04.2022 | Despatch of a communication from the examining division (Time limit: M04) | 24.06.2022 | Reply to a communication from the examining division | 15.03.2023 | Communication of intention to grant the patent | 11.07.2023 | Receipt of the translation of the claim(s) | 12.07.2023 | Fee for grant paid | 12.07.2023 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP16756594.4 / EP3328987 | Opposition(s) | 03.06.2024 | No opposition filed within time limit [2024/32] | Fees paid | Renewal fee | 31.01.2020 | Renewal fee patent year 03 | 31.01.2020 | Renewal fee patent year 04 | 23.07.2020 | Renewal fee patent year 05 | 26.07.2021 | Renewal fee patent year 06 | 27.07.2022 | Renewal fee patent year 07 | 26.07.2023 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 28.07.2016 | HU | 28.07.2016 | BG | 30.08.2023 | CZ | 30.08.2023 | DK | 30.08.2023 | EE | 30.08.2023 | FI | 30.08.2023 | HR | 30.08.2023 | LT | 30.08.2023 | LV | 30.08.2023 | MC | 30.08.2023 | NL | 30.08.2023 | PL | 30.08.2023 | RO | 30.08.2023 | RS | 30.08.2023 | SE | 30.08.2023 | SI | 30.08.2023 | SK | 30.08.2023 | SM | 30.08.2023 | NO | 30.11.2023 | GR | 01.12.2023 | IS | 30.12.2023 | PT | 02.01.2024 | [2026/16] |
| Former [2026/10] | CY | 28.07.2016 | |
| BG | 30.08.2023 | ||
| CZ | 30.08.2023 | ||
| DK | 30.08.2023 | ||
| EE | 30.08.2023 | ||
| FI | 30.08.2023 | ||
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| MC | 30.08.2023 | ||
| NL | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RO | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| SI | 30.08.2023 | ||
| SK | 30.08.2023 | ||
| SM | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| PT | 02.01.2024 | ||
| Former [2025/11] | BG | 30.08.2023 | |
| CZ | 30.08.2023 | ||
| DK | 30.08.2023 | ||
| EE | 30.08.2023 | ||
| FI | 30.08.2023 | ||
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| MC | 30.08.2023 | ||
| NL | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RO | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| SI | 30.08.2023 | ||
| SK | 30.08.2023 | ||
| SM | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| PT | 02.01.2024 | ||
| Former [2024/51] | BG | 30.08.2023 | |
| CZ | 30.08.2023 | ||
| DK | 30.08.2023 | ||
| EE | 30.08.2023 | ||
| FI | 30.08.2023 | ||
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| NL | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RO | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| SI | 30.08.2023 | ||
| SK | 30.08.2023 | ||
| SM | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| PT | 02.01.2024 | ||
| Former [2024/36] | CZ | 30.08.2023 | |
| DK | 30.08.2023 | ||
| EE | 30.08.2023 | ||
| FI | 30.08.2023 | ||
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| NL | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RO | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| SI | 30.08.2023 | ||
| SK | 30.08.2023 | ||
| SM | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| PT | 02.01.2024 | ||
| Former [2024/23] | CZ | 30.08.2023 | |
| DK | 30.08.2023 | ||
| EE | 30.08.2023 | ||
| FI | 30.08.2023 | ||
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| NL | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RO | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| SK | 30.08.2023 | ||
| SM | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| PT | 02.01.2024 | ||
| Former [2024/22] | CZ | 30.08.2023 | |
| DK | 30.08.2023 | ||
| FI | 30.08.2023 | ||
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| NL | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RO | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| SM | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| Former [2024/20] | FI | 30.08.2023 | |
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| NL | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| SM | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| Former [2024/14] | FI | 30.08.2023 | |
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| NL | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| Former [2024/10] | FI | 30.08.2023 | |
| HR | 30.08.2023 | ||
| LT | 30.08.2023 | ||
| LV | 30.08.2023 | ||
| PL | 30.08.2023 | ||
| RS | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| Former [2024/09] | FI | 30.08.2023 | |
| LT | 30.08.2023 | ||
| SE | 30.08.2023 | ||
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | ||
| IS | 30.12.2023 | ||
| Former [2024/08] | LT | 30.08.2023 | |
| NO | 30.11.2023 | ||
| GR | 01.12.2023 | Documents cited: | Search | [A] US2011100921 (HEINRICH HANS-WERNER et al.) | [A] WO2013000897 (GE HEALTHCARE UK LTD et al.) | [A] US2014017779 (WAICHE GAEL et al.) [A] 1-15 * figures 1,2; claim 1 * | Examination | US4957637 | US3931010 |